BUY REC Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))20 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·21 Jul · today
ACME Solar Secures INR 2,646.64 Crore REC Funding For 450 MW/1,800 MWh FDRE Project
NewsGoogle News·16 Jul · 4d ago
ACME Solar secures Rs 2,646.64 crore funding for FDRE project from REC
NewsGoogle News·16 Jul · 4d ago
ACME Solar Secures ₹2,647 Crore from REC for 450 MW FDRE Project
NewsGoogle News·16 Jul · 4d ago
ACME Solar secures Rs 2,646 crore project financing from REC Ltd
NewsGoogle News·16 Jul · 5d ago
REC fined ₹5.31 lakh for board composition non-compliance
NewsGoogle News·14 Jul · 6d ago
REC seeks waiver of fines related to board composition non-compliance
NewsGoogle News·14 Jul · 6d ago
REC Ltd fined ₹5.31 lakh by NSE, BSE for board composition lapse; seeks waiver
NewsGoogle News·14 Jul · 6d ago
REC Ltd ને ₹5.31 લાખનો દંડ: NSE અને BSE દ્વારા બોર્ડ કમ્પોઝિશનમાં ક્ષતિ બદલ કાર્યવાહી, કંપનીએ માંગી માફી
NewsGoogle News·14 Jul · 6d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on REC
- BUY — Manas Jaiswal14 Oct 2026 · ~2 weeks · target ₹330 · SL hit
- SELL — Manas Jaiswal5 Oct 2026 · Same day · target ₹280 · SL hit
- SELL — Manas Jaiswal1 Oct 2026 · ~2 weeks · target ₹276 · SL hit
- BUY — Laxmikant Shukla, YES Securities16 Sept 2026 · ~2 weeks · target ₹325 · Expired
- BUY — Bernstein25 Aug 2026 · ~1 year · target ₹410 · Active
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

